At a glance
- Originator Mitsubishi Pharma Corporation
- Class Anti-inflammatories; Antiallergics; Antiasthmatics
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 31 Dec 2001 Discontinued - Phase-II for Asthma in Japan (Inhalation)
- 31 Dec 2001 Discontinued - Phase-II for Asthma in Japan (PO)
- 19 Oct 2001 No-Development-Reported for Asthma in Japan (Inhalation)